{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:53:00Z","timestamp":1785333180116,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.anndiagpath.2006.06.010","type":"journal-article","created":{"date-parts":[[2007,7,14]],"date-time":"2007-07-14T12:40:02Z","timestamp":1184416802000},"page":"235-240","source":"Crossref","is-referenced-by-count":12,"title":["Immunohistochemical detection of X-linked inhibitor of apoptosis (XIAP) in neoplastic and other thyroid disorders"],"prefix":"10.1016","volume":"11","author":[{"given":"Guang-Qian","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela D.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Burstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2006.06.010_bib1","doi-asserted-by":"crossref","first-page":"27058","DOI":"10.1074\/jbc.M102415200","article-title":"X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes","volume":"276","author":"Suzuki","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.cr.7290046","article-title":"The IAP family: endogenous caspase inhibitors with multiple biological activities","volume":"10","author":"Yang","year":"2000","journal-title":"Cell Res"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1535-7163.699.3.6","article-title":"X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells","volume":"3","author":"Amantana","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.10776","article-title":"Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro","volume":"103","author":"Bilim","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s00262-004-0534-8","article-title":"Expression of IAP family proteins in colon cancers from patients with different age groups","volume":"53","author":"Endo","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000014631","article-title":"Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant?","volume":"9","author":"Li","year":"2000","journal-title":"Biol Signals Recept"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.yexmp.2004.01.001","article-title":"Expression of IAP family proteins in esophageal cancer","volume":"76","author":"Nemoto","year":"2004","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.humpath.2004.03.011","article-title":"XIAP expression is an independent prognostic marker in clear-cell renal carcinomas","volume":"35","author":"Ramp","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib9","first-page":"3327","article-title":"Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence","volume":"23","author":"Schultz","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib10","first-page":"705","article-title":"Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma","volume":"12","author":"Shiraki","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib11","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1038\/sj.onc.1207929","article-title":"XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer","volume":"23","author":"Cao","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib12","first-page":"231","article-title":"X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells","volume":"26","author":"Roa","year":"2003","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.thj.6200549","article-title":"XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis","volume":"5","author":"Tamm","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib14","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1182\/blood-2004-07-2716","article-title":"Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas","volume":"105","author":"Muris","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/excr.2002.5608","article-title":"Expression of inhibitor of apoptosis proteins in small- and non\u2013small-cell lung carcinoma cells","volume":"279","author":"Ekedahl","year":"2002","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib16","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0959-8049(01)00085-5","article-title":"Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma","volume":"37","author":"Liu","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib17","first-page":"A4457","article-title":"Phenoxodiol phase Ib\/II study in patients with recurrent ovarian cancer that are resistant to second-line chemotherapy [abstr]","volume":"95","author":"Rutherford","year":"2004","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3727\/0965040042707943","article-title":"Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol","volume":"14","author":"Sapi","year":"2004","journal-title":"Oncol Res"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib19","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1038\/sj.onc.1206739","article-title":"BRAF mutations in papillary carcinomas of the thyroid","volume":"22","author":"Fukushima","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/EP:13:1:03","article-title":"RET\/PTC rearrangement in thyroid tumors","volume":"13","author":"Nikiforov","year":"2002","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib21","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/00000478-200012000-00005","article-title":"Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics","volume":"24","author":"Cheung","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"Suppl","key":"10.1016\/j.anndiagpath.2006.06.010_bib22","first-page":"3","article-title":"Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status","volume":"22","author":"Schlumberger","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.humpath.2003.10.027","article-title":"Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis","volume":"35","author":"Burstein","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/106689690201000213","article-title":"RET\/PTC rearrangements in Hashimoto's thyroiditis","volume":"10","author":"Sheils","year":"2002","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2559.2002.01467.x","article-title":"Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma","volume":"41","author":"Arif","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib26","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1210\/jc.84.11.4246","article-title":"Fas (CD95) expression is up-regulated on papillary thyroid carcinoma","volume":"84","author":"Arscott","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/hupa.2001.21138","article-title":"Pathologic features of Hashimoto's-associated papillary thyroid carcinomas","volume":"32","author":"Di Pasquale","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib28","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1038\/sj.onc.1203765","article-title":"Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death","volume":"19","author":"Holcik","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1011379307472","article-title":"XIAP: apoptotic brake and promising therapeutic target","volume":"6","author":"Holcik","year":"2001","journal-title":"Apoptosis"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib30","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.2003.06.012","article-title":"Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance","volume":"21","author":"Bannerji","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib31","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/sj.onc.1203679","article-title":"TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention","volume":"19","author":"Ahmad","year":"2000","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"10.1016\/j.anndiagpath.2006.06.010_bib32","first-page":"S71","article-title":"TRAIL and anti-tumor responses","volume":"2","author":"Bhojani","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2559.2005.02221.x","article-title":"Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy","volume":"47","author":"de Matos","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1309\/UUQTE505PTN5QJ7M","article-title":"The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer","volume":"122","author":"Weber","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198409000-00005","article-title":"Poorly differentiated (insular) thyroid carcinoma. A reinterpretation of Langhans \u201cwuchernde struma\u201d","volume":"8","author":"Carcangiu","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2006.06.010_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/thy.1998.8.715","article-title":"Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches","volume":"8","author":"Ain","year":"1998","journal-title":"Thyroid"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913406000827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913406000827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T09:51:45Z","timestamp":1683971505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913406000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1092913406000827"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2006.06.010","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}